Cargando…

Clinical and biochemical heterogeneity between patients with glycogen storage disease type IA: the added value of CUSUM for metabolic control

OBJECTIVE: To study heterogeneity between patients with glycogen storage disease type Ia (GSD Ia), a rare inherited disorder of carbohydrate metabolism caused by the deficiency of glucose-6-phosphatase (G6Pase). STUDY DESIGN: Descriptive retrospective study of longitudinal clinical and biochemical d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peeks, Fabian, Steunenberg, Thomas A. H., de Boer, Foekje, Rubio-Gozalbo, M. Estela, Williams, Monique, Burghard, Rob, Rajas, Fabienne, Oosterveer, Maaike H., Weinstein, David A., Derks, Terry G. J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5579135/ https://www.ncbi.nlm.nih.gov/pubmed/28397058 http://dx.doi.org/10.1007/s10545-017-0039-1

Ejemplares similares

A retrospective in‐depth analysis of continuous glucose monitoring datasets for patients with hepatic glycogen storage disease: Recommended outcome parameters for glucose management
por: Peeks, Fabian, et al.
Publicado: (2021)

A Prospective Study on Continuous Glucose Monitoring in Glycogen Storage Disease Type Ia: Toward Glycemic Targets
por: Rossi, Alessandro, et al.
Publicado: (2022)

Impaired Very‐Low‐Density Lipoprotein catabolism links hypoglycemia to hypertriglyceridemia in Glycogen Storage Disease type Ia
por: Hoogerland, Joanne A., et al.
Publicado: (2021)

Next-generation glycogen storage diseases
por: Derks, Terry G. J., et al.
Publicado: (2018)

High childhood serum triglyceride concentrations associate with hepatocellular adenoma development in patients with glycogen storage disease type Ia
por: Haring, Martijn P.D., et al.
Publicado: (2022)

The potential of dietary treatment in patients with glycogen storage disease type IV
por: Derks, Terry G. J., et al.
Publicado: (2020)

A preliminary study of telemedicine for patients with hepatic glycogen storage disease and their healthcare providers: from bedside to home site monitoring
por: Hoogeveen, Irene J., et al.
Publicado: (2018)

Glycogen storage disease type 1a is associated with disturbed vitamin A metabolism and elevated serum retinol levels
por: Saeed, Ali, et al.
Publicado: (2020)

Glycogen Storage Disease Type Ia: Current Management Options, Burden and Unmet Needs
por: Derks, Terry G. J., et al.
Publicado: (2021)

Normalization of hepatic ChREBP activity does not protect against liver disease progression in a mouse model for Glycogen Storage Disease type Ia
por: Rutten, Martijn G. S., et al.
Publicado: (2023)

A retrospective study of eating and psychosocial problems in patients with hepatic glycogen storage diseases and idiopathic ketotic hypoglycemia: Towards a standard set of patient‐reported outcome measures
por: Venema, Annieke, et al.
Publicado: (2021)

Glycogen storage disease type Ia: Adult presentation with microcytic anemia and liver adenomas
por: Moest, Wouter, et al.
Publicado: (2018)

The multiple faces of urinary glucose tetrasaccharide as biomarker for patients with hepatic glycogen storage diseases
por: Heiner-Fokkema, M. Rebecca, et al.
Publicado: (2020)

Towards values‐based healthcare for inherited metabolic disorders: An overview of current practices for persons with liver glycogen storage disease and fatty acid oxidation disorders
por: Venema, Annieke, et al.
Publicado: (2022)

Increased atherosclerosis in a mouse model of glycogen storage disease type 1a
por: La Rose, Anouk M., et al.
Publicado: (2022)

Hepatic Carbohydrate Response Element Binding Protein Activation Limits Nonalcoholic Fatty Liver Disease Development in a Mouse Model for Glycogen Storage Disease Type 1a
por: Lei, Yu, et al.
Publicado: (2020)

A triple-blinded crossover study to evaluate the short-term safety of sweet manioc starch for the treatment of glycogen storage disease type Ia
por: Monteiro, Vaneisse C. L., et al.
Publicado: (2021)

‘Instant’ cusums from a discrete analyser
por: Henry, P., et al.
Publicado: (1985)

Cusum analysis for learning curve of videothoracoscopic lobectomy
por: Gezer, Suat, et al.
Publicado: (2016)

CUSUM Residual Charts for Monitoring Enterovirus Infections
por: Chen, Huifen, et al.
Publicado: (2013)

A New Class of Weighted CUSUM Statistics
por: Shi, Xiaoping, et al.
Publicado: (2022)

Geneotype and phenotype in 20 patients with glycogen storage disease type Ia
por: Liang, Cuili, et al.
Publicado: (2013)

Estimation of Health Utility Scores for Glycogen Storage Disease Type Ia
por: Kruger, Eliza, et al.
Publicado: (2023)

Research priorities for liver glycogen storage disease: An international priority setting partnership with the James Lind Alliance
por: Peeks, Fabian, et al.
Publicado: (2019)

Glycogen Storage Disease Type Ia in Canines: A Model for Human Metabolic and Genetic Liver Disease
por: Specht, Andrew, et al.
Publicado: (2011)

CUSUM: A tool for early feedback about performance?
por: Chang, Winston R, et al.
Publicado: (2006)

The CUSUM statistic of change point under NA sequences
por: Ling, Jin, et al.
Publicado: (2021)

Modeling the patient mix for risk-adjusted CUSUM charts
por: Wittenberg, Philipp
Publicado: (2022)

Monitoring surgical quality: the cumulative sum (CUSUM) approach
por: Novoa, Nuria M., et al.
Publicado: (2020)

Dietary lipids in glycogen storage disease type III: A systematic literature study, case studies, and future recommendations
por: Rossi, Alessandro, et al.
Publicado: (2020)

Exosomal MicroRNAs as Potential Biomarkers of Hepatic Injury and Kidney Disease in Glycogen Storage Disease Type Ia Patients
por: Resaz, Roberta, et al.
Publicado: (2021)

Lipids in hepatic glycogen storage diseases: pathophysiology, monitoring of dietary management and future directions
por: Derks, Terry G. J., et al.
Publicado: (2015)

Modeling Phenotypic Heterogeneity of Glycogen Storage Disease Type 1a Liver Disease in Mice by Somatic CRISPR/CRISPR‐associated protein 9–Mediated Gene Editing
por: Rutten, Martijn G.S., et al.
Publicado: (2021)

Advanced glycation end products and the absence of premature atherosclerosis in glycogen storage disease Ia
por: den Hollander, N. C., et al.
Publicado: (2007)

Continuous glucose monitoring in the treatment of obesity in patients with glycogen storage disease type Ia
por: Korljan Jelaska, Betty, et al.
Publicado: (2013)

Hepatic mitochondrial dysfunction is a feature of Glycogen Storage Disease Type Ia (GSDIa)
por: Farah, Benjamin L., et al.
Publicado: (2017)

Comment on the CUSUM surgical learning curve analysis in Dimitrovska et al. (2022)
por: Rakovich, George, et al.
Publicado: (2022)

Change point detection for neuronal data with CUSUM and classification methods
por: Koepcke, Lena, et al.
Publicado: (2013)

Spatial CUSUM Chart Based Method for Rapid Detection of Outbreaks
por: Dassanayaka, Sesha K.
Publicado: (2015)

Laparoscopic Pectopexy—CUSUM Learning Curve and Perioperative Complications Analysis
por: Szymczak, Paulina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bjvi606jg04o49c1rrocesmaen